Alchemab Therapeutics
Drug DiscoveryWebsite
Developer of natural protective antibodies designed to keep people free of hard-to-treat diseases in a transformative approach. The company's antibodies are found through an unbiased and function-firs...
Valuation
$0
Share Price
N/A
Total Raised
$32.1M
Last Round
Later Stage VC (Series A)
Sep 2025
Latest Funding Round
Later Stage VC (Series A)
Sep 9, 2025
$31.9M
raised
Investors
+11 other investors